Plus, #AUA2025 news from Protara Therapeutics, Pfizer, CG Oncology, and UroGen, in addition to the latest updates from Spruce Biosciences and Rezolute:
Biohaven’s up to $600M financing deal: The Connecticut drugmaker will get $250 million ...
↧